Table 2 Comparison of study results with Just et al.’s PGx survey [8].

From: Pharmacogenomics to optimise psychotropic prescribing: a survey of mental health professionals’ perceptions, knowledge, and educational needs

Experience of, and attitudes toward, PGx

Study results, %

Just et al., %

Adjusted p-value

Is PGx relevant to my current practice?

70.9

84.3

ns

Have you ordered or recommended a PGx test in the past year?

18.3

34.3

ns

Is PGx a factor that you consider for drug dosing?

13.6

18.6

ns

Self-assessed familiarity with PGx

Pharmacology and drug metabolism

63.5

85.8

**

The role of drug metaboliser phenotypes

47.2

75.7

***

Genetics

36.8

78.6

****

Interpreting the results of a PGx test

16.7

51.4

****

PGx knowledge-testing questions

Correct

47.1

41

ns

Incorrect / no response

52.9

59

ns

PGx learning preferences

Accredited learning course

52.4

60

ns

CME-accredited workshop

54.3

55.7

ns

E-learning course

47.6

47.1

ns

Patient cases

55.2

44.3

ns

Scientific article

31.4

44.3

ns

  1. A table comparing this study’s survey results with Just et al.’s findings from 2017 [8]. Percentage values from Just et al.’s study were taken from the manuscript main text. Two proportion z-tests were used to statistically compare the two groups. Just et al. report a sample size of 70, which was used to calculate proportions, and sample numbers for this study are as reported in previous figures. Adjusted p-values were generated using the false discovery rate correction method, and these are shown as significance stars.
  2. ns Not Significant.
  3. **p <0.01.
  4. ***p <0.001.
  5. ****p <0.0001.
Back to article page